一种融合学习方法,用于对阿尔茨海默病的亚组分析
Mingming Liu1, Jing Yang2, Yushi Liu3
1Department of Statistics, University of California at Riverside, Riverside, CA, USA.
Journal of applied statistics
|June 1, 2023
概括
这项研究使用形融合学习识别了不同的阿尔茨海默病进展子组. 这种方法有助于理解疾病的异质性,并开发个性化的精密医学治疗方法.
科学领域:
- 神经科学是一个神经科学.
- 生物统计学 生物统计学
- 计算生物学 计算生物学
背景情况:
- 阿尔茨海默病 (AD) 的进展是异质的,使治疗开发复杂化.
- 识别不同的患者亚组对于AD的精准医学方法至关重要.
- 由于未知的个体轨迹,当前的方法在准确识别子组成员时面临挑战.
研究的目的:
- 根据共同的进展模式,识别阿尔茨海默病患者的潜在子组.
- 预测个别子组成员的情况.
- 估计和推断在已识别的子组中异构的疾病轨迹.
主要方法:
- 形融合学习方法的应用,用于对纵向阿尔茨海默病数据的子组分析.
- 使用B-spline对特定主题函数的近似来表示异质轨迹.
- 同时估计分离系数和合并,用于子组识别和轨迹恢复.
主要成果:
- 在阿尔茨海默病进展过程中成功识别了潜在的子组.
- 每个子组的不同,异质的疾病轨迹的恢复.
- 开发的方法提供了一个估计子组轨迹的估计器与非对称分布支持.
结论:
- 形融合学习有效地解决了在阿尔茨海默病研究中未知子组成员的挑战.
- 这种方法可以更深入地了解AD异质性,为定制干预铺平道路.
- 理论基础支持在复杂疾病中进行亚组分析的统计推理.
相关概念视频
01:26Alzheimer's Disease: Overview
539
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
539
01:22Alzheimer's Disease: Treatment
226
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
226